1. Home
  2. LFVN vs SCLX Comparison

LFVN vs SCLX Comparison

Compare LFVN & SCLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lifevantage Corporation (Delaware)

LFVN

Lifevantage Corporation (Delaware)

HOLD

Current Price

$4.40

Market Cap

54.9M

Sector

Health Care

ML Signal

HOLD

Logo Scilex Holding Company

SCLX

Scilex Holding Company

HOLD

Current Price

$6.33

Market Cap

52.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LFVN
SCLX
Founded
N/A
2011
Country
United States
United States
Employees
N/A
30
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
54.9M
52.9M
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
LFVN
SCLX
Price
$4.40
$6.33
Analyst Decision
Hold
Analyst Count
0
1
Target Price
N/A
N/A
AVG Volume (30 Days)
97.6K
30.7K
Earning Date
05-05-2026
05-13-2026
Dividend Yield
4.19%
N/A
EPS Growth
226.09
N/A
EPS
0.19
N/A
Revenue
$203,204,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$749.70
P/E Ratio
$22.63
N/A
Revenue Growth
1.86
N/A
52 Week Low
$3.90
$0.18
52 Week High
$16.14
$34.27

Technical Indicators

Market Signals
Indicator
LFVN
SCLX
Relative Strength Index (RSI) 38.05 30.18
Support Level $4.32 $4.56
Resistance Level $5.37 $7.50
Average True Range (ATR) 0.29 0.62
MACD -0.04 -0.13
Stochastic Oscillator 23.70 3.50

Price Performance

Historical Comparison
LFVN
SCLX

About LFVN Lifevantage Corporation (Delaware)

Lifevantage Corp is engaged in the identification, research, development, and distribution of nutraceutical dietary supplements and skincare products. It offers products such as Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skincare product; Axio energy drink mixes; and PhysIQ, a weight management system and other product Geographically, its products are sold in the regions of the United States, Japan, Hong Kong, Australia, Canada, Philippines, Mexico, Thailand, the United Kingdom, and the Netherlands.

About SCLX Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.

Share on Social Networks: